Josep Sarrà

1.4k total citations
25 papers, 623 citations indexed

About

Josep Sarrà is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Josep Sarrà has authored 25 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 8 papers in Oncology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Josep Sarrà's work include Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). Josep Sarrà is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). Josep Sarrà collaborates with scholars based in Spain and Czechia. Josep Sarrà's co-authors include Rodrigo Martino, Carlos Solano, Jesús F. San Miguel, Jorge Sierra, Josè Antonio Pérez-Simón, Carmen Canals, Joan Bargay, Álvaro Urbano-Ispizúa, Marı́a Dolores Caballero and Salut Brunet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Josep Sarrà

24 papers receiving 613 citations

Peers

Countries citing papers authored by Josep Sarrà

Since Specialization

Citations

This map shows the geographic impact of Josep Sarrà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Sarrà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Sarrà more than expected).

Fields of papers citing papers by Josep Sarrà

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep Sarrà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Sarrà. The network helps show where Josep Sarrà may publish in the future.

Co-authorship network of co-authors of Josep Sarrà

This figure shows the co-authorship network connecting the top 25 collaborators of Josep Sarrà. A scholar is included among the top collaborators of Josep Sarrà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep Sarrà. Josep Sarrà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD200 genotype is associated with clinical outcome of patients with multiple myeloma 2024 ·Frontiers in Immunology ·(unknown), Gemma Osca‐Gelis, Rocío Rodriguez, (unknown), (unknown), (unknown), (unknown), Albert Oriol, Anna Sureda, Lourdes Escoda, Josep Sarrà, (unknown), (unknown), (unknown), Isabel Granada, David Gallardo	1
2	Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma 2023 ·Frontiers in Immunology ·(unknown), Rocío Rodriguez, (unknown), Gemma Osca‐Gelis, (unknown), (unknown), (unknown), Albert Oriol, Anna Sureda, Lourdes Escoda, Josep Sarrà, (unknown), (unknown), Isabel de la Torre Díez, Isabel Granada, David Gallardo	5
3	Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies 2022 ·International Journal of Hematology ·Ana Carla Oliveira, (unknown), Christelle Ferrá, (unknown), (unknown), Maite Encuentra, Eva Domingo‐Doménech, (unknown), David Gallardo, Josep‐María Ribera, Josep Sarrà, Anna Sureda, Eva González‐Barca	1
4	Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis 2020 ·SHILAP Revista de lepidopterología ·Rocío Parody, Isabel Sánchez‐Ortega, Christelle Ferrá, Ramón Guàrdia, Carme Talarn, Maite Encuentra, (unknown), (unknown), Mireia Morgades, (unknown), (unknown), Josep Sarrà, David Gallardo, Josep‐María Ribera, Anna Sureda	1
5	20‐year follow‐up of Hodgkin lymphoma: Predictors of survival and secondary malignancies 2017 ·Hematological Oncology ·(unknown), Carme Talarn, Marta Cervera, (unknown), Josep Gumà, (unknown), (unknown), (unknown), (unknown), Xavier Ortı́n, (unknown), (unknown), (unknown), (unknown), Alejandra Martínez, Josep Sarrà, Lourdes Escoda	1
6	Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols 2016 ·Leukemia & lymphoma ·(unknown), Josep‐María Ribera, Mireia Morgades, Isabel Granada, Pau Montesinos, Salut Brunet, Juan Bergua, Mar Tormo, Raimundo García‐Boyero, Josep Sarrà, Eloy del Potro, Carlos Grande, Pere Barba, Teresa Bernal, María‐Luz Amigo, Javier Grau, José Cervera, Evarist Feliú, (unknown)	6
7	Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy 2015 ·Leukemia & lymphoma ·(unknown), David Gallardo, José González‐Campos, Jesús María Hernández‐Rivas, Pau Montesinos, Josep Sarrà, Cristina Gil, Pere Barba, Ramón Guàrdia, Salut Brunet, Teresa Bernal, (unknown), Eugènia Abella, (unknown), (unknown), Antònia Cladera, Jorge Gayoso, María Calbacho, Josep‐María Ribera, (unknown)	11
8	Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols 2015 ·Cancer ·Jordi Ribera, Mireia Morgades, Lurdes Zamora, Pau Montesinos, Inés Gómez‐Seguí, Marta Pratcorona, Josep Sarrà, Ramón Guàrdia, Josep Nomdedéu, Mar Tormo, Joaquín Martínez‐López, Jesús María Hernández‐Rivas, José González‐Campos, Pere Barba, Lourdes Escoda, Eulàlia Genescà, Françesc Solé, Fuensanta Millá, Evarist Feliú, Josep‐María Ribera, (unknown)	36
9	Multiple Myeloma Presenting as Bilateral Posterior Optic Neuropathy 2010 ·Neuro-Ophthalmology ·Silvia Muñoz, (unknown), Jorge Arruga, Antonio Vidaller, Carles Majós, Josep Sarrà	1
10	Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial 2009 ·Haematologica ·Josep‐María Ribera, Albert Oriol, Marcos González, María‐Belén Vídriales, S. Brunet, Jordi Esteve, Eloy del Potro, C Rivas, (unknown), Mar Tormo, (unknown), Josep Sarrà, Ricardo Parody, Jaime Pérez de Oteyza, E Bureo, Teresa Bernal, (unknown)	128
11	Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial 2004 ·Bone Marrow Transplantation ·(unknown), Rodrigo Martino, Marı́a Dolores Caballero, Josè Antonio Pérez-Simón, Carmen Canals, María‐Victoria Mateos, Josep Sarrà, Agathe León, Carlos Solano, José M. Moraleda, Álvaro Urbano-Ispizúa, Joan Besalduch, Jesús F. San Miguel, Jorge Sierra	34
12	Richter's syndrome after allogeneic stem cell transplantation for chronic lymphocytic leukaemia successfully treated by withdrawal of immunosuppression, and donor lymphocyte infusion 2003 ·Bone Marrow Transplantation ·Ignacio Español, Tomáš Büchler, Christelle Ferrá, David Gallardo, (unknown), Josep Sarrà, A Domingo, V. Romagosa, A Grañena	15
13	Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes 2002 ·Blood ·Rodrigo Martino, Marı́a Dolores Caballero, Josè Antonio Pérez-Simón, Carmen Canals, Carlos Solano, Álvaro Urbano-Ispizúa, Joan Bargay, (unknown), Josep Sarrà, Guillermo Sanz, José M. Moraleda, Salut Brunet, Jesús F. San Miguel, Jorge Sierra	141
14	Allogeneic peripheral blood stem cell transplantation with reduced‐intensity conditioning: results of a prospective multicentre study 2001 ·British Journal of Haematology ·Rodrigo Martino, Marı́a Dolores Caballero, Carmen Canals, Josè Antonio Pérez-Simón, Carlos Solano, Álvaro Urbano-Ispizúa, Joan Bargay, (unknown), Antonio Léon, Josep Sarrà, J Odriozola, (unknown), Jorge Sierra, Jesús F. San Miguel	96
15	Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation 2001 ·Bone Marrow Transplantation ·Christelle Ferrá, (unknown), David Gallardo, Maite Encuentra, (unknown), (unknown), (unknown), Josep Sarrà, (unknown), Joan Garcı́a, A Grañena	16
16	Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation 2001 ·Bone Marrow Transplantation ·Rodrigo Martino, (unknown), Carmen Canals, Jesús F. San Miguel, Jorge Sierra, M Rovira, Carlos Solano, Joan Bargay, Josè Antonio Pérez-Simón, Agathe León, Josep Sarrà, Salut Brunet, Rafael de la Cámara	63
17	Treatment with interleukin-2 (IL-2) and interferon (IFNalpha 2b) after autologous bone marrow or peripheral blood stem cell transplantation in onco-hematological malignancies with a high risk of relapse 1999 ·Bone Marrow Transplantation ·P Vivancos, A Grañena, Josep Sarrà	12
18	Feasibility of ESHAP + G-CSF as Peripheral Blood Hematopoietic Progenitor Cell Mobilisation Regimen in Resistant and Relapsed Lymphoma: a Single-Center Study of 22 Patients 1999 ·Leukemia & lymphoma ·J Petit, (unknown), (unknown), Josep Sarrà, Juan José Múñoz, Juan Carlos García‐Ruiz, A Grañena	17
19	Umbilical cord blood transplantation from unrelated donors in an adult weighing 90 kilograms. Role of immunosuppression in engraftment 1997 ·Bone Marrow Transplantation ·Eva González‐Barca, Sergio Querol, A Grañena, Josep Sarrà, G. Sirchia, (unknown)	5
20	Thrombin-antithrombin complexes and prothrombin fragment 1+2 in aorto-coronary bypass surgery: relation to graft occlusion. 1994 ·PubMed ·J. Rifón, José A. Páramo, Felipe Prósper, (unknown), Josep Sarrà, Eduardo Rocha	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact